Addressing the Global Expertise Gap in Radiation Oncology: The Radiation Planning Assistant.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
07 2023
Historique:
medline: 23 10 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: ppublish

Résumé

Automation, including the use of artificial intelligence, has been identified as a possible opportunity to help reduce the gap in access and quality for radiotherapy and other aspects of cancer care. The Radiation Planning Assistant (RPA) project was conceived in 2015 (and funded in 2016) to use automated contouring and treatment planning algorithms to support the efforts of oncologists in low- and middle-income countries, allowing them to scale their efforts and treat more patients safely and efficiently (to increase access). In this review, we discuss the development of the RPA, with a particular focus on clinical acceptability and safety/risk across jurisdictions as these are important indicators for the successful future deployment of the RPA to increase radiotherapy availability and ameliorate global disparities in access to radiation oncology. RPA tools will be offered through a webpage, where users can upload computed tomography data sets and download automatically generated contours and treatment plans. All interfaces have been designed to maximize ease of use and minimize risk. The current version of the RPA includes automated contouring and planning for head and neck cancer, cervical cancer, breast cancer, and metastases to the brain. The RPA has been designed to bring high-quality treatment planning to more patients across the world, and it may encourage greater investment in treatment devices and other aspects of cancer treatment.

Identifiants

pubmed: 37471671
doi: 10.1200/GO.22.00431
pmc: PMC10581646
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200431

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Références

J Glob Oncol. 2016 May 25;2(5):311-340
pubmed: 28717717
J Appl Clin Med Phys. 2019 Feb;20(2):51-62
pubmed: 30636358
J Appl Clin Med Phys. 2022 Aug;23(8):e13704
pubmed: 35791594
Lancet Oncol. 2015 Sep;16(10):1153-86
pubmed: 26419354
J Appl Clin Med Phys. 2022 Sep;23(9):e13694
pubmed: 35775105
Clin Oncol (R Coll Radiol). 2022 Feb;34(2):74-88
pubmed: 34996682
J Appl Clin Med Phys. 2022 Sep;23(9):e13712
pubmed: 35808871
Med Dosim. 2020 Spring;45(1):102-107
pubmed: 31956001
Med Phys. 2020 Nov;47(11):5648-5658
pubmed: 32964477
J Glob Oncol. 2019 Jan;5:1-9
pubmed: 30629457
Oncology. 2021;99(2):124-134
pubmed: 33352552
Pract Radiat Oncol. 2021 Sep-Oct;11(5):415-423
pubmed: 33711488
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
J Glob Oncol. 2017 Jan 11;3(5):563-571
pubmed: 29094096
JCO Glob Oncol. 2022 May;8:e2100431
pubmed: 35537104
J Appl Clin Med Phys. 2023 Mar;24(3):e13839
pubmed: 36412092
Pract Radiat Oncol. 2020 Sep - Oct;10(5):e415-e424
pubmed: 32450365
Clin Oncol (R Coll Radiol). 2023 Apr;35(4):219-226
pubmed: 36725406
Med Phys. 2019 Nov;46(11):5086-5097
pubmed: 31505046
J Appl Clin Med Phys. 2021 May;22(5):168-174
pubmed: 33779037
Br J Radiol. 2023 Mar 1;96(1144):20220707
pubmed: 36728760
Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):516-528
pubmed: 35787928
J Appl Clin Med Phys. 2021 Sep;22(9):94-102
pubmed: 34250715
J Appl Clin Med Phys. 2022 Aug;23(8):e13647
pubmed: 35580067
Semin Radiat Oncol. 2019 Jul;29(3):185-197
pubmed: 31027636
Med Dosim. 2020 Summer;45(2):172-178
pubmed: 31740042
Med Phys. 2019 Jun;46(6):2567-2574
pubmed: 31002389
Pract Radiat Oncol. 2022 Jul-Aug;12(4):e344-e353
pubmed: 35305941
Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):801-812
pubmed: 33068690
Semin Radiat Oncol. 2020 Oct;30(4):340-347
pubmed: 32828389
Lancet Oncol. 2022 Jun;23(6):e251-e312
pubmed: 35550267
Med Phys. 2022 Sep;49(9):5742-5751
pubmed: 35866442
Med Dosim. 2019 Winter;44(4):339-343
pubmed: 30611624
Pract Radiat Oncol. 2021 May-Jun;11(3):177-184
pubmed: 33640315

Auteurs

Laurence Court (L)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Ajay Aggarwal (A)

Guy's and St Thomas' Hospital, London, United Kingdom.

Hester Burger (H)

Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Carlos Cardenas (C)

University of Alabama and Birmingham, Birmingham, AL.

Christine Chung (C)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Raphael Douglas (R)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Monique du Toit (M)

Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa.

David Jaffray (D)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Anuja Jhingran (A)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Michael Mejia (M)

Benavides Cancer Institute, University of Santo Tomas, Manila, Philippines.

Raymond Mumme (R)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Sikudhani Muya (S)

Ocean Road Cancer Institute, Dar es Salaam, Tanzania.

Komeela Naidoo (K)

Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa.

Jerry Ndumbalo (J)

Ocean Road Cancer Institute, Dar es Salaam, Tanzania.

Kelly Nealon (K)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Tucker Netherton (T)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Callistus Nguyen (C)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Niki Olanrewaju (N)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Jeannette Parkes (J)

Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Willie Shaw (W)

University of the Free State, Bloemfontein, South Africa.

Christoph Trauernicht (C)

Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa.

Melody Xu (M)

University of California San Francisco, San Francisco, CA.

Jinzhong Yang (J)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Lifei Zhang (L)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Hannah Simonds (H)

University Hospitals Plymouth, Plymouth, United Kingdom.

Beth M Beadle (BM)

Stanford University, Stanford, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH